Canada markets closed

Crinetics Pharmaceuticals, Inc. (CRNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
43.32-0.90 (-2.04%)
At close: 04:00PM EDT
43.30 -0.02 (-0.05%)
After hours: 05:38PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.38B
Enterprise Value 2.87B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)626.87
Price/Book (mrq)6.26
Enterprise Value/Revenue 714.95
Enterprise Value/EBITDA -12.95

Trading Information

Stock Price History

Beta (5Y Monthly) 0.62
52-Week Change 3131.78%
S&P500 52-Week Change 322.64%
52 Week High 349.58
52 Week Low 315.76
50-Day Moving Average 342.56
200-Day Moving Average 331.69

Share Statistics

Avg Vol (3 month) 3804.8k
Avg Vol (10 day) 3604.59k
Shares Outstanding 577.93M
Implied Shares Outstanding 679.57M
Float 864.75M
% Held by Insiders 11.94%
% Held by Institutions 197.13%
Shares Short (Mar 28, 2024) 44.91M
Short Ratio (Mar 28, 2024) 45
Short % of Float (Mar 28, 2024) 46.92%
Short % of Shares Outstanding (Mar 28, 2024) 46.30%
Shares Short (prior month Feb 29, 2024) 44.74M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-5,547.17%

Management Effectiveness

Return on Assets (ttm)-28.18%
Return on Equity (ttm)-50.16%

Income Statement

Revenue (ttm)4.01M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)N/A
EBITDA -221.51M
Net Income Avi to Common (ttm)-214.53M
Diluted EPS (ttm)-3.69
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)558.56M
Total Cash Per Share (mrq)8.03
Total Debt (mrq)51.73M
Total Debt/Equity (mrq)9.59%
Current Ratio (mrq)13.07
Book Value Per Share (mrq)7.91

Cash Flow Statement

Operating Cash Flow (ttm)-166.31M
Levered Free Cash Flow (ttm)-93.53M